Champions Oncology, Inc. (CSBR) Social Stream



Champions Oncology, Inc. (CSBR): $9.40

0.00 (0.00%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add CSBR to Watchlist
Sign Up

Industry: Biotech


Ranked

of 494

in industry

Champions Oncology Inc (CSBR) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering CSBR.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-12-15 1 $16 $14 $15 $8.26 81.6%
2022-03-22 1 $13 $13 $13 $8.26 57.38%

Price Target Last Issued March 22, 2022

The Trend in the Analyst Price Target


CSBR's average price target has moved down $2.67 over the prior 33 weeks.

CSBR reports an average of 54.77% for its upside potential over the past 50 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-05 0 16 14 15.00 11.72 27.99%
2021-05-22 0 16 14 15.00 10.03 49.55%
2021-08-14 1 17 14 15.67 10.79 45.23%
2021-09-19 1 17 14 15.67 10.34 51.55%
2021-12-15 1 16 16 16.00 7.84 104.08%

CSBR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • Champions Oncology Inc's number of analysts covering the stock is higher than practically none of all US stocks.
  • In the context of Pharmaceutical Products stocks, Champions Oncology Inc's variance in analysts' estimates is lower than 90.04% of them.
  • In the context of Healthcare stocks, Champions Oncology Inc's average analyst price target is greater than 73.14% of them.
  • In terms of how Champions Oncology Inc fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is higher than 87.47% of that group.

Stocks similar to Champions Oncology Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are CRXT, CGTX, and CDTX.

Is CSBR a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.483 seconds.